Search research articles
Contact Us
Filters
Showing results (1-10 of 76) with videos related to
Page
of 8
Sort By:
Frontiers in Medicine
|
March 30, 2018
Optimum Use of Acute Treatments for Hereditary Angioedema: Evidence-Based Expert Consensus
Hilary Longhurst
Current Opinion in Investigational Drugs (London, England : 2000)
|
March 4, 2008
Rhucin, a recombinant C1 inhibitor for the treatment of hereditary angioedema and cerebral ischemia
Hilary Longhurst
Lancet (London, England)
|
February 7, 2012
Hereditary angio-oedema
Hilary Longhurst, Marco Cicardi
Expert Opinion on Biological Therapy
|
January 30, 2020
Biological therapy in hereditary angioedema: transformation of a rare disease
Hilary Longhurst, Henriette Farkas
Clinical Reviews in Allergy & Immunology
|
July 9, 2016
The Humanistic, Societal, and Pharmaco-economic Burden of Angioedema
Hilary Longhurst, Anette Bygum
Immunology and Allergy Clinics of North America
|
July 9, 2017
Prophylactic Therapy for Hereditary Angioedema
Hilary Longhurst, Emily Zinser
Clinical Reviews in Allergy & Immunology
|
May 18, 2021
Mitigating Disparity in Health-care Resources Between Countries for Management of Hereditary Angioedema
Ankur Kumar Jindal, Avner Reshef, Hilary Longhurst, et al.
Frontiers in Allergy
|
November 28, 2022
Editorial: C1 inhibitor deficiency and angioedema
Henriette Farkas, Anastasios E Germenis, Hilary Longhurst
Clinical Reviews in Allergy & Immunology
|
July 8, 2021
Comparison of Diagnostic Criteria for Common Variable Immunodeficiency Disorders (CVID) in the New Zealand CVID Cohort Study
Rohan Ameratunga, Hilary Longhurst, Richard Steele, et al.
Practical Neurology
|
October 23, 2014
Longitudinally extensive transverse myelitis: a rare association with common variable immunodeficiency
Edwin Jabbari, Charles Robert Marshall, Hilary Longhurst, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 76) with videos related to
Sort By:
Page
of 8
Frontiers in Medicine
|
March 30, 2018
Optimum Use of Acute Treatments for Hereditary Angioedema: Evidence-Based Expert Consensus
Hilary Longhurst
Current Opinion in Investigational Drugs (London, England : 2000)
|
March 4, 2008
Rhucin, a recombinant C1 inhibitor for the treatment of hereditary angioedema and cerebral ischemia
Hilary Longhurst
Lancet (London, England)
|
February 7, 2012
Hereditary angio-oedema
Hilary Longhurst, Marco Cicardi
Expert Opinion on Biological Therapy
|
January 30, 2020
Biological therapy in hereditary angioedema: transformation of a rare disease
Hilary Longhurst, Henriette Farkas
Clinical Reviews in Allergy & Immunology
|
July 9, 2016
The Humanistic, Societal, and Pharmaco-economic Burden of Angioedema
Hilary Longhurst, Anette Bygum
Immunology and Allergy Clinics of North America
|
July 9, 2017
Prophylactic Therapy for Hereditary Angioedema
Hilary Longhurst, Emily Zinser
Clinical Reviews in Allergy & Immunology
|
May 18, 2021
Mitigating Disparity in Health-care Resources Between Countries for Management of Hereditary Angioedema
Ankur Kumar Jindal, Avner Reshef, Hilary Longhurst, et al.
Frontiers in Allergy
|
November 28, 2022
Editorial: C1 inhibitor deficiency and angioedema
Henriette Farkas, Anastasios E Germenis, Hilary Longhurst
Clinical Reviews in Allergy & Immunology
|
July 8, 2021
Comparison of Diagnostic Criteria for Common Variable Immunodeficiency Disorders (CVID) in the New Zealand CVID Cohort Study
Rohan Ameratunga, Hilary Longhurst, Richard Steele, et al.
Practical Neurology
|
October 23, 2014
Longitudinally extensive transverse myelitis: a rare association with common variable immunodeficiency
Edwin Jabbari, Charles Robert Marshall, Hilary Longhurst, et al.
Page
of 8